已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Primary Ewing sarcoma of the kidney: A series of four cases.

医学 CD99 肾切除术 组织病理学 肉瘤 尤因肉瘤 病理 化疗 活检 免疫组织化学 外科 内科学 波形蛋白
作者
Sanjiban Patra,Priti Trivedi
出处
期刊:PubMed 卷期号:44 (1): 93-99 被引量:3
链接
标识
摘要

Ewing sarcoma (ES), the neuroectodermal derived tumour typically occurs in the bone and soft tissue of children and young adults. Primary ES of the kidney is strikingly rare and only a few cases and small case series have been documented. Due to the highly aggressive nature of this neoplasm, distinction from other morphological mimickers is truly indispensable in terms of treatment and prognosis. Here we describe the clinicopathological features of four cases of primary ES of the kidney with special emphasis on one case having extensive neural differentiation postneo- adjuvant chemotherapy (NACT). Extensive neural differentiation in renal ES has not been documented to date.Four patients (age range from 15-35 years) had kidney mass and multiple distant metastases at first presentation. Primary diagnosis of Ewing sarcoma was rendered by histopathology with the help of immunohistochemistry on core biopsy material. Tumour cells in all cases showed diffuse membranous CD99, nuclear FLI-1 and NKX2.2. Two of the patients had undergone radical nephrectomy followed by combination chemotherapy. Another two patients were first treated with neo-adjuvant chemotherapy (NACT) followed by radical nephrectomy. In one of them, histopathological examination of nephrectomy specimens revealed extensive neural differentiation. The adrenal gland was free in all four cases. The follow-up period was 12 -24 months. Three patients had survived and one of them became disease-free.Primary ES of the kidney is a rare and lethal entity. Due to overwhelming rarity, chemotherapy protocol has not been standardised and followed as ES in bone/soft tissue. Histopathological confirmation and prompt initiation of treatment may improve patient survival and outcome.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
bkagyin应助archer01采纳,获得10
4秒前
油个大饼呜呜呜完成签到,获得积分20
4秒前
4秒前
九九完成签到,获得积分10
4秒前
urochen完成签到 ,获得积分10
5秒前
酷波er应助xAnny采纳,获得10
7秒前
chenxiaoyin完成签到,获得积分10
7秒前
Hale完成签到,获得积分0
9秒前
烟花应助jiaobuyimi采纳,获得10
11秒前
张泽宇完成签到,获得积分10
11秒前
iceink发布了新的文献求助200
11秒前
CYM发布了新的文献求助10
13秒前
阳光芫完成签到,获得积分10
13秒前
15秒前
赵可欣完成签到,获得积分10
15秒前
jiaobuyimi完成签到,获得积分10
16秒前
16秒前
yc发布了新的文献求助10
17秒前
axiao完成签到,获得积分10
18秒前
双黄应助xh采纳,获得10
18秒前
pyt发布了新的文献求助10
19秒前
科研通AI2S应助rylynn采纳,获得10
21秒前
小蘑菇应助科研通管家采纳,获得10
22秒前
22秒前
科研通AI2S应助科研通管家采纳,获得10
22秒前
科研通AI2S应助科研通管家采纳,获得10
22秒前
齐齐巴宾应助pyt采纳,获得10
22秒前
jiaobuyimi发布了新的文献求助10
23秒前
激动的南风完成签到,获得积分10
24秒前
眯缝着眼完成签到,获得积分10
27秒前
29秒前
ggg04228完成签到,获得积分20
29秒前
31秒前
yuaner完成签到,获得积分10
32秒前
33秒前
33秒前
archer01发布了新的文献求助10
36秒前
Akim应助小叶不吃香菜采纳,获得10
38秒前
yuaner发布了新的文献求助10
39秒前
DX完成签到,获得积分10
39秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Very-high-order BVD Schemes Using β-variable THINC Method 830
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3248577
求助须知:如何正确求助?哪些是违规求助? 2892044
关于积分的说明 8269473
捐赠科研通 2560089
什么是DOI,文献DOI怎么找? 1388851
科研通“疑难数据库(出版商)”最低求助积分说明 650913
邀请新用户注册赠送积分活动 627798